Evidence map›Paper›PMID 32793815›Full record

ArticleInnovation in aging2020

A Strategy to Prepare Primary Care Clinicians for Discussing Stopping Cancer Screening With Adults Older Than 75 Years.

Mara A Schonberg, Maria Karamourtopoulos, Alicia R Jacobson, Gianna M Aliberti, Adlin Pinheiro, Alexander K Smith, Roger B Davis, Linnaea C Schuttner, Mary Beth Hamel

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in Innovation in aging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03480282 nacompletednot on this map

Discussing Stopping Cancer Screening and Prognosis With Older Adults

TypeinterventionalSponsorBeth Israel Deaconess Medical CenterRan2017 to 2021Enrolled90ConditionsCancer ScreeningArmsPrognosis information and Provider Scripts
NCT06896474 narecruitingnot on this mapstarted 2026, after this paper: background citation

SDM POSSIBLE: A Cluster RCT of a Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers

TypeinterventionalSponsorBeth Israel Deaconess Medical CenterRan2026 to 2033Enrolled402ConditionsBreast CancerArmsShared Decision-Making Training and Decision Aid
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Mara A SchonbergBeth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.ORCID 0000-0001-5162-5922
Maria KaramourtopoulosBeth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
Alicia R JacobsonBeth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
Gianna M AlibertiBeth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
Adlin PinheiroBeth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
Alexander K SmithDivision of Geriatrics, Department of Medicine, University of California San Francisco.
Roger B DavisBeth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
Linnaea C SchuttnerHealth Services Research & Development, VA Puget Sound Health Care System, Seattle, Washington.
Mary Beth HamelBeth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
Beth Israel Deaconess Medical Center · USUniversity of California, San Francisco · USUniversity of Washington · US

Funding

Discussions of Prognosis and Stopping Cancer Screening in Older AdultsR21CA212386 · NCI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI SCHONBERG, MARA A · 2017 to 2018
$425k
NCI NIH HHS R21 CA212386
6 · The paper itself

Abstract

BACKGROUND AND

objectivesAdults older than 75 years are overscreened for cancer, especially those with less than 10-year life expectancy. This study aimed to learn the effects of providing primary care providers (PCPs) with scripts for discussing stopping mammography and colorectal cancer (CRC) screening and with information on patient's 10-year life expectancy on their patients' intentions to be screened for these cancers. RESEARCH DESIGN AND

methodsPatient participants, identified via PCP appointment logs, completed a questionnaire pre- and postvisit. Primary care providers were given scripts for discussing stopping screening and information on patient's 10-year life expectancy before these visits. Primary care providers completed a questionnaire at the end of the study. Patients and PCPs were asked about discussing stopping cancer screening and patient life expectancy. Patient screening intentions (1-15 Likert scale; lower scores suggest lower intentions) were compared pre- and postvisit using the Wilcoxon signed-rank test.

resultsNinety patients older than 75 years (47% of eligible patients reached by phone) from 45 PCPs participated. Patient mean age was 80.0 years ( DISCUSSION AND IMPLICATIONS: PCPs found scripts for discussing stopping cancer screening and information on patient life expectancy helpful. Possibly, as a result, their patients older than 75 years had lower intentions of being screened for CRC. CLINICAL TRIALS REGISTRATION NUMBER: NCT03480282.

Indexed as

Cancer preventionDeimplementationOverscreening

Identifiers

PMID32793815
PMCPMC7413618
OpenAlexW3039170891

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.